Can obesity cause cancer?

Share This Post

Obesity not only runs counter to the aesthetics of people, but also causes many chronic diseases. Some studies have shown that body mass index (BMI) is related to the risk of cancer in certain parts (such as the digestive system), but there is no unified conclusion on the relationship with cancer in other parts. An umbrella review published in Annals of Oncology at the end of 2017, comprehensively analyzing the relationship between 26 BMI and cancer riskta analysis, and strive to bring the most authoritative conclusions to readers.

The study only included evaluation of the quantitative response between BMI and the risk of cancer analysis, a total of 26 articles. Use umbrella review (ie multiple meta analysis to review), re-analyzed the relationship between BMI and 20 types of cancer.

The results of the study showed that five types of cancer (leukemia, multiple myeloma, pancreatic cancer, endometrial cancer, rectal cancer, and renal cell carcinoma) had the highest correlation strength with BMI; three types of cancer (malignant melanoma, non-Hodgkin) Lymphoma and esophageal adenocarcinoma) and BMI reach a moderate level of strength; for brain and central nervous system tumors, breast cancer, colon cancer, gallbladder cancer, lung cancer, liver cancer, ovarian cancer and thyroid cancer, there is a low-grade BMI Degree of association; there is no association between the occurrence of bladder cancer, gastric cancer and prostate cancer and BMI.

The relationship between increased BMI and the occurrence of cancer varies greatly between different cancers. According to analysis, the occurrence of leukemia, multiple myeloma, pancreatic cancer, endometrial cancer, rectal cancer and renal cell carcinoma is strongly associated with the increase in BMI.

Body mass index and 20-specific cancers: re-analyses of dose-response meta-analyses of observational studies. Ann Oncol. 2017 Dec 28. doi: 10.1093 / annonc / mdx819. 

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Claudin18.2-targeted CAR-T cell therapy brings complete remission in advanced pancreatic cancer patient A case report
CAR T-Cell therapy

Claudin18.2-targeted CAR-T cell therapy brings complete remission in advanced pancreatic cancer patient : A case report

Claudin18.2-targeted CAR-T cell therapy has shown remarkable potential in treating advanced pancreatic cancer, as highlighted in a recent case report. This innovative approach led to complete remission in a patient with advanced disease, underscoring the promise of targeted immunotherapy. By leveraging the specific expression of Claudin18.2 on cancer cells, this therapy offers a precision-based treatment, heralding a new era in pancreatic cancer management with significant clinical implications.

What is the treatment after BCMA CAR T failed in RR multiple myeloma cases
CAR T-Cell therapy

What is the treatment after BCMA CAR T failed in R/R multiple myeloma cases?

For people with relapsed or refractory multiple myeloma, BCMA CAR T-cell therapy might not work. Other treatments, such as bispecific antibodies, other CAR T-cell therapies that target different antigens, and combination regimens with immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies, can still be used. OriCAR-017 is another immunotherapy that is under trial and is expected to be launched soon. Clinical trials offer experimental treatments, providing access to novel therapies. Tailored approaches based on patient-specific factors and emerging research are crucial for improving outcomes in this challenging scenario.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy